Quality and Safety
The House Oversight Committee said PBMs are distorting the pharmaceutical market and limiting high-quality care.
Much can be learned from donating UpToDate to middle- and low-income countries, including how access to evidence-based clinical guidance can reduce barriers anywhere, says Wolters Kluwer Health CMO Dr. Peter Bonis.
Apparent differences in potentially avoidable hospitalizations among MA plans may be explained by shifting inpatient care to other settings.
According to Optum, there's a high unmet need for treatments for Alzheimer's disease, as current treatments have lacked efficacy.
CMS says it must examine whether a medication is reasonable and necessary while the FDA assesses whether medications are safe and effective.
MA plans have adopted more restrictive criteria commonly used by commercial health insurance carriers, found consulting firm Crowe.
Patients in such models were 18% less likely to be admitted to the hospital and had a 9% lower 30-day readmission rate.
On April 1, states can begin disenrolling Medicaid enrollees for the first time since March 2020.
According to TPP UK's director of research and analytics Dr. Chris Bates, records that are made for clinicians and directly shareable with patients are essential to high-quality data.
Elevance expects the deal will help it fill the specialty drug needs of clients by using a whole-health focus.